scPharmaceuticals Inc. Logo

scPharmaceuticals Inc.

Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.

SCPH | US

Overview

Corporate Details

ISIN(s):
US8106481059
LEI:
Country:
United States of America
Address:
25 BURLINGTON MALL ROAD, SUITE 203, 1803 BURLINGTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

scPharmaceuticals Inc. is a commercial-stage pharmaceutical company, operating as a subsidiary of MannKind Corporation, focused on developing and commercializing patient-centric treatments for cardiorenal diseases. The company specializes in drug-device combinations that facilitate subcutaneous drug delivery, aiming to improve patient outcomes and shift care from clinical settings to the home. Its flagship product, FUROSCIX®, is a proprietary formulation of furosemide delivered via an auto-injector for treating congestion in patients with heart failure and, as of 2025, chronic kidney disease. The company's strategy centers on creating value-based solutions that reduce the burden of care and enhance quality of life for patients with cardiovascular and renal conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all scPharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for scPharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for scPharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania
SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan
4559
ZEVRA THERAPEUTICS, INC. Logo
A commercial-stage biopharma developing and delivering therapies for rare diseases.
United States of America
ZVRA
Zhengye Biotechnology Holding Ltd Logo
Researches, makes, and sells veterinary vaccines for China's livestock industry, focusing on swine.
United States of America
ZYBT
Zoetis Inc. Logo
Develops medicines, vaccines, and diagnostics for the health of livestock and companion animals.
United States of America
ZTS
Zura Bio Ltd Logo
Developing novel dual-pathway therapies for severe autoimmune and inflammatory conditions.
United States of America
ZURA
Zymeworks Inc. Logo
Develops multifunctional biotherapeutics to treat cancer and other serious diseases.
United States of America
ZYME
株式会社PRISM BioLab Logo
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
Japan
206A

Talk to a Data Expert

Have a question? We'll get back to you promptly.